{
    "8000": {
        "explanation_text": "Displaced fracture of second metatarsal bone, left foot, initial encounter for closed fracture.",
        "symptom_text": "The patient has no history of foot fractures or significant trauma to the left foot.The patient presented with localized pain, swelling, and tenderness on the dorsal aspect of the left foot after a fall.X-ray imaging of the left foot revealed a displaced fracture of the second metatarsal bone.Displaced fracture of the second metatarsal bone, left foot, initial encounter for closed fracture. The patient sustained a closed displaced fracture of the second metatarsal bone in the left foot.The patient's left foot was immobilized with a cast, and pain management was initiated.The patient was prescribed pain medication and advised to follow up with an orthopedic specialist for further evaluation.The patient was discharged in stable condition with instructions to keep weight off the left foot and follow up with the orthopedic specialist in one week.45FemaleCaucasian"
    },
    "8001": {
        "explanation_text": "Displaced fracture of third metatarsal bone, left foot, initial encounter for closed fracture.",
        "symptom_text": "The patient has no history of fractures or foot injuries.The patient presented with acute onset severe pain, swelling, and bruising on the dorsum of the left foot after accidentally dropping a heavy object on it.X-ray of the left foot revealed a displaced fracture of the third metatarsal bone.Displaced fracture of third metatarsal bone, left foot, initial encounter for closed fracture. Verbatim EHR quote: 'Patient diagnosed with a displaced fracture of the third metatarsal bone in the left foot following trauma.'The patient is in good general health with no systemic symptoms. The fracture is closed without any signs of infection.The patient's left foot was immobilized with a cast, and pain management was initiated with acetaminophen. Instructions for non-weight bearing ambulation were given.The patient was discharged with a follow-up appointment scheduled in two weeks for cast removal and reevaluation of the fracture.42FemaleCaucasian"
    },
    "8002": {
        "explanation_text": "Displaced fracture of fourth metatarsal bone, left foot, initial encounter for closed fracture.",
        "symptom_text": "The patient has no history of foot fractures or significant injuries.The patient presented with localized pain, swelling, and tenderness on the left foot, specifically over the fourth metatarsal bone.X-ray imaging revealed a displaced fracture of the fourth metatarsal bone in the left foot.Displaced fracture of fourth metatarsal bone, left foot, initial encounter for closed fracture. The patient sustained a closed displaced fracture of the fourth metatarsal bone in the left foot.Clinical examination and imaging confirmed the diagnosis of a displaced fracture of the fourth metatarsal bone in the left foot. No other associated injuries were noted.The patient's foot was immobilized with a cast, and pain management was initiated. Instructions for non-weight bearing and follow-up were provided.The patient was discharged in stable condition with arrangements for follow-up care to monitor the healing process of the fractured metatarsal bone.45FemaleCaucasian"
    },
    "8003": {
        "explanation_text": "Displaced fracture of fifth metatarsal bone, right foot, initial encounter for closed fracture.",
        "symptom_text": "The patient has no history of fractures or significant foot injuries.The patient presented with acute pain, swelling, and difficulty bearing weight on the right foot after a fall.X-ray of the right foot revealed a displaced fracture of the fifth metatarsal bone.Displaced fracture of fifth metatarsal bone, right foot, initial encounter for closed fracture. The patient sustained an injury resulting in a displaced fracture of the fifth metatarsal bone in the right foot.Physical examination showed tenderness, swelling, and ecchymosis over the base of the right fifth metatarsal. Neurovascular exam of the right foot was intact.The patient's right foot was immobilized with a short leg cast. Pain management was achieved with oral analgesics. Instructions for non-weight bearing ambulation were given.The patient was discharged in stable condition with a scheduled follow-up appointment for cast removal and further evaluation.42FemaleCaucasian"
    },
    "8004": {
        "explanation_text": "Sprain of unspecified ligament of left ankle, initial encounter.",
        "symptom_text": "The patient has a history of occasional ankle sprains during physical activities.The patient presented with left ankle pain, swelling, and difficulty bearing weight after twisting the ankle during a basketball game.X-ray of the left ankle showed no evidence of a fracture.Sprain of unspecified ligament of left ankle, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with left ankle pain, swelling, and tenderness after twisting the ankle during a basketball game. X-ray findings are negative for any fractures.'Upon examination, the patient has localized tenderness over the lateral aspect of the left ankle with mild swelling. No ecchymosis noted. X-ray findings negative for fractures, consistent with a ligament sprain.RICE protocol (Rest, Ice, Compression, Elevation) advised. Ankle brace provided for support. Nonsteroidal anti-inflammatory drug (NSAID) prescribed for pain management.Patient instructed on RICE protocol and advised to follow up in one week for reassessment.28MaleCaucasian"
    },
    "8005": {
        "explanation_text": "Other foreign object in bronchus causing asphyxiation, initial encounter.",
        "symptom_text": "The patient has no history of respiratory issues or foreign body aspirations.The patient presented with sudden onset shortness of breath, coughing, wheezing, and cyanosis.Chest X-ray revealed the presence of a foreign object in the bronchus.Other foreign object in bronchus causing asphyxiation, initial encounter (T17.590A) - The patient aspirated a foreign object into the bronchus resulting in asphyxiation.The patient's oxygen saturation was low, and auscultation revealed decreased breath sounds on the affected side.Immediate bronchoscopy performed to remove the foreign object. Oxygen therapy and respiratory support initiated.The patient responded well to treatment, and oxygen saturation levels normalized. Discharged with instructions for follow-up care.45MaleCaucasian"
    },
    "8006": {
        "explanation_text": "Food in other parts of respiratory tract causing asphyxiation, initial encounter.",
        "symptom_text": "The patient has no history of respiratory issues or foreign body aspiration.The patient presented with sudden onset coughing, choking, and difficulty breathing after accidentally inhaling a piece of food.Chest X-ray showed signs of air trapping in the affected lung segment.Food in other parts of respiratory tract causing asphyxiation, initial encounter. Verbatim EHR quote justifying the code: 'Patient accidentally inhaled a piece of food leading to asphyxiation.'Upon examination, patient was in distress, with decreased breath sounds on the right side. No signs of musculoskeletal injury were noted.Immediate removal of the food particle through bronchoscopy. Oxygen therapy and monitoring for respiratory distress.Patient's condition improved post-procedure, with no signs of respiratory distress. Advised on eating slowly and chewing food thoroughly to prevent future incidents.45FemaleCaucasian"
    },
    "8007": {
        "explanation_text": "Food in respiratory tract, part unspecified causing asphyxiation, initial encounter.",
        "symptom_text": "The patient has no history of respiratory issues or foreign body aspiration.The patient presented with sudden choking, coughing, and difficulty breathing after ingesting food.Chest X-ray showed air trapping and hyperinflation in the lungs.Food in respiratory tract, part unspecified causing asphyxiation, initial encounter. The patient ingested food that obstructed the respiratory tract, leading to asphyxiation.The patient's airway was partially obstructed by food material, causing respiratory distress.Immediate removal of the food material through bronchoscopy was performed to clear the airway. Oxygen therapy and monitoring for respiratory function were initiated.The patient responded well to treatment, with no further respiratory distress. Discharged with instructions for dietary modifications to prevent future incidents.45MaleCaucasian"
    },
    "8008": {
        "explanation_text": "Other foreign object in esophagus causing other injury, initial encounter.",
        "symptom_text": "The patient has no history of esophageal disorders or foreign body ingestion.The patient presented with dysphagia, odynophagia, and localized chest pain.X-ray imaging revealed a foreign object in the esophagus with no signs of asphyxiation or respiratory distress.Foreign object in esophagus causing other injury, initial encounter. Verbatim EHR quote justifying the code: 'Foreign object in esophagus causing mucosal laceration and localized inflammation.'Upon examination, there were no signs of respiratory distress or asphyxiation. The patient's airway was patent, and breath sounds were clear bilaterally.The patient underwent esophagoscopy for foreign body removal and received analgesics for pain management.The patient was discharged in stable condition with instructions for a soft diet and to follow up with the gastroenterologist in two weeks.45FemaleCaucasian"
    },
    "8009": {
        "explanation_text": "Foreign body in colon, initial encounter.",
        "symptom_text": "The patient has no history of gastrointestinal disorders or surgeries.The patient presented with abdominal pain localized in the lower left quadrant, constipation, and rectal bleeding.Abdominal X-ray revealed the presence of a radiopaque foreign body in the descending colon.Foreign body in colon, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Abdominal X-ray confirmed the presence of a radiopaque foreign body in the descending colon.'The patient reported accidental ingestion of a small object a week ago, correlating with the onset of symptoms. Physical examination showed tenderness in the lower left abdomen.The patient was scheduled for a colonoscopy to determine the size and nature of the foreign body and plan for its removal.45FemaleCaucasian"
    },
    "8010": {
        "explanation_text": "Adverse effect of penicillins, initial encounter.",
        "symptom_text": "The patient has a history of penicillin allergy documented in previous medical records.The patient presents with a diffuse rash, itching, and mild facial swelling shortly after receiving a dose of penicillin.Skin prick testing confirmed a positive reaction to penicillin.Adverse effect of penicillins, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with a diffuse rash, itching, and mild facial swelling shortly after receiving a dose of penicillin.'The patient's symptoms are consistent with a mild allergic reaction to penicillins. No signs of respiratory distress or asphyxiation observed.Administered antihistamines, topical corticosteroids, and advised to avoid penicillin and related antibiotics.The patient's symptoms improved with treatment, and there were no further complications upon discharge.42FemaleCaucasian"
    },
    "8011": {
        "explanation_text": "Adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter.",
        "symptom_text": "The patient has a history of recurrent urinary tract infections and has been prescribed cephalosporins in the past without any adverse effects.The patient presents with generalized rash, itching, and mild facial swelling.Skin prick test positive for cephalosporins. No eosinophilia noted in the complete blood count.Adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with generalized rash, itching, and mild facial swelling after exposure to cephalosporins. Skin prick test positive for cephalosporins.'Patient denies any respiratory symptoms, gastrointestinal complaints, or history of anaphylaxis. No signs of infection at the rash site.Administered antihistamines for symptomatic relief. Cephalosporins discontinued. Advised to avoid cephalosporins and related antibiotics in the future.Patient's symptoms improved with treatment. Discharged with instructions to follow up with an allergist for further evaluation and to carry an epinephrine auto-injector in case of future severe reactions.45FemaleCaucasian"
    },
    "8012": {
        "explanation_text": "Adverse effect of macrolides, initial encounter.",
        "symptom_text": "The patient has a history of recurrent respiratory infections and was prescribed azithromycin, a macrolide antibiotic, for the current upper respiratory tract infection.The patient presents with nausea, vomiting, and a diffuse rash shortly after taking the first dose of azithromycin.Laboratory tests show elevated liver enzymes consistent with a drug-induced hepatotoxicity.Adverse effect of macrolides, initial encounter. Verbatim EHR quote justifying the code: 'Patient developed nausea, vomiting, and a diffuse rash shortly after initiating azithromycin, with elevated liver enzymes on laboratory tests.'The patient reports no history of foreign body ingestion or aspiration. The adverse effects observed are consistent with a known reaction to macrolide antibiotics.Discontinuation of azithromycin. Symptomatic treatment for nausea and rash. Close monitoring of liver function tests.The patient's symptoms improved with supportive care, and liver enzymes normalized before discharge.45FemaleCaucasian"
    },
    "8013": {
        "explanation_text": "Adverse effect of tetracyclines, initial encounter.",
        "symptom_text": "The patient has a history of acne vulgaris and was recently started on oral tetracycline therapy.The patient presents with nausea, vomiting, and a generalized rash after initiating tetracycline treatment.Laboratory tests show no evidence of foreign objects or burns. Allergy testing is pending.Adverse effect of tetracyclines, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient developed nausea, vomiting, and a generalized rash shortly after starting tetracycline therapy.'The patient reports that symptoms started within hours of taking the first dose of tetracycline. No signs of respiratory distress or airway obstruction noted.Discontinuation of tetracycline therapy. Prescribed antihistamines for rash and antiemetics for nausea and vomiting. Follow-up scheduled in one week.28FemaleCaucasian"
    },
    "8014": {
        "explanation_text": "Adverse effect of aminoglycosides, initial encounter.",
        "symptom_text": "The patient has a history of recurrent urinary tract infections and was prescribed aminoglycosides for the first time.The patient presents with symptoms of nausea, vomiting, and dizziness after the administration of aminoglycosides.Renal function tests show a mild elevation in serum creatinine levels, consistent with aminoglycoside-induced nephrotoxicity.Adverse effect of aminoglycosides, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with nausea, vomiting, and dizziness following the administration of aminoglycosides. Renal function tests reveal elevated serum creatinine levels, indicating aminoglycoside-induced nephrotoxicity.'The physician notes the temporal relationship between aminoglycoside administration and the onset of symptoms, as well as the laboratory findings supporting nephrotoxicity.The patient was immediately switched to an alternative antibiotic, and supportive care was initiated to manage the adverse effects.After symptom resolution and normalization of renal function tests, the patient was discharged with instructions to avoid aminoglycosides in the future.58FemaleCaucasian"
    },
    "8015": {
        "explanation_text": "Underdosing of rifampicins, initial encounter.",
        "symptom_text": "The patient has a history of tuberculosis and has been prescribed rifampicins as part of the treatment regimen.The patient is not presenting with any new symptoms related to adverse effects of rifampicins, such as gastrointestinal disturbances, skin reactions, or neurological symptoms.Recent blood tests show subtherapeutic levels of rifampicins in the patient's system, indicating underdosing.Underdosing of rifampicins, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with subtherapeutic levels of rifampicins in the blood, consistent with underdosing.'The physician notes that the patient has been non-adherent to the prescribed rifampicins regimen, leading to the underdosing.The patient will be counseled on the importance of adherence to the rifampicins regimen. The dose will be adjusted, and close monitoring of drug levels will be initiated.N/A45MaleCaucasian"
    },
    "8016": {
        "explanation_text": "Adverse effect of other systemic antibiotics, initial encounter.",
        "symptom_text": "The patient has no known allergies to antibiotics and has not experienced adverse effects from any systemic antibiotics in the past.The patient presented with generalized urticaria, mild dyspnea, and mild gastrointestinal discomfort shortly after taking a newly prescribed systemic antibiotic.Laboratory tests revealed an elevated total IgE level and negative findings for infectious causes.Adverse effect of other systemic antibiotics, initial encounter. Verbatim EHR quote justifying the code: 'Patient developed generalized urticaria, mild dyspnea, and mild gastrointestinal discomfort shortly after taking a newly prescribed systemic antibiotic.'The patient denied any recent changes in diet, exposure to new allergens, or insect bites. Vital signs were stable, and no signs of anaphylaxis were present.The patient was treated with intravenous antihistamines, corticosteroids, and observation for 24 hours. The offending antibiotic was discontinued.The patient's symptoms resolved without complications. Discharge instructions include avoiding the antibiotic in question and seeking immediate medical attention if similar symptoms recur.45FemaleCaucasian"
    },
    "8017": {
        "explanation_text": "Adverse effect of other antiprotozoal drugs, initial encounter.",
        "symptom_text": "The patient has no known history of allergies to antiprotozoal drugs. No previous adverse reactions to similar medications have been reported.The patient presents with nausea, vomiting, and generalized weakness after taking antiprotozoal medication.Laboratory tests show normal electrolyte levels and liver function tests within the reference range.Adverse effect of other antiprotozoal drugs, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with nausea, vomiting, and generalized weakness after taking antiprotozoal medication.'The patient reports the onset of symptoms shortly after starting the antiprotozoal drug. No other evident cause for the symptoms.Discontinuation of the antiprotozoal medication. Symptomatic treatment with antiemetics and hydration.The patient's symptoms improved with supportive care, and they were discharged with instructions to avoid the offending medication.45FemaleCaucasian"
    },
    "8018": {
        "explanation_text": "Adverse effect of antiviral drugs, initial encounter.",
        "symptom_text": "The patient has a history of recurrent herpes simplex virus (HSV) infections and is currently on antiviral medication.The patient complains of nausea, vomiting, and headache.Laboratory tests show normal liver and kidney function.Adverse effect of antiviral drugs, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with adverse effects after the initial dose of antiviral medication.'The patient's symptoms are consistent with an adverse reaction to the antiviral drug prescribed.Discontinuation of the antiviral medication, symptomatic treatment for nausea and headache, and close monitoring of the patient's condition.The patient's symptoms improved with treatment, and they were discharged with instructions to follow up if any new symptoms arise.42FemaleCaucasian"
    },
    "8019": {
        "explanation_text": "Underdosing of antiviral drugs, initial encounter.",
        "symptom_text": "The patient has a history of recurrent viral infections requiring antiviral therapy.The patient presents with persistent fever, generalized weakness, and malaise.Laboratory tests show elevated viral load and decreased levels of antiviral drugs in the bloodstream.Underdosing of antiviral drugs, initial encounter. Verbatim EHR quote justifying the code: 'The patient presents with symptoms consistent with underdosing of antiviral drugs, confirmed by laboratory tests showing decreased levels of antiviral drugs in the bloodstream.'The physician notes the importance of optimizing the antiviral drug regimen to achieve therapeutic levels and improve the patient's condition.The patient is started on a higher dose of antiviral medication, and close monitoring of drug levels is planned.The patient responded well to the adjusted antiviral therapy and is discharged with instructions for follow-up drug level monitoring.45MaleCaucasian"
    },
    "8020": {
        "explanation_text": "Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter.",
        "symptom_text": "The patient has a history of recurrent urinary tract infections and has been prescribed various systemic anti-infectives and antiparasitics in the past.The patient presents with generalized rash, itching, and mild nausea.Laboratory tests show normal complete blood count and liver function tests.Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with generalized rash and itching, consistent with an adverse effect of other specified systemic anti-infectives and antiparasitics.'Patient denies any shortness of breath, chest pain, or swelling. No signs of infection at the rash site. Suspected adverse reaction to the systemic anti-infectives and antiparasitics.Discontinuation of the current medication. Prescribed antihistamines for symptomatic relief. Advised to follow up if symptoms worsen.Patient's symptoms improved with antihistamines. Advised to avoid the offending medication in the future.45FemaleCaucasian"
    },
    "8021": {
        "explanation_text": "Adverse effect of glucocorticoids and synthetic analogues, initial encounter.",
        "symptom_text": "The patient has a history of asthma and was recently prescribed prednisone for the management of an acute exacerbation.The patient presents with increased blood pressure, fluid retention, and insomnia following the initiation of glucocorticoid therapy.Laboratory tests show no electrolyte abnormalities or signs of infection.Adverse effect of glucocorticoids and synthetic analogues, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with increased blood pressure, fluid retention, and insomnia following the initiation of glucocorticoid therapy.'The patient reports that the symptoms started shortly after beginning prednisone. No other potential causes for the symptoms were identified.Discontinuation of prednisone. Initiation of a tapering regimen with close monitoring of symptoms. Recommendation for lifestyle modifications to manage blood pressure.45FemaleCaucasian"
    },
    "8022": {
        "explanation_text": "Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter.",
        "symptom_text": "The patient has a history of asthma and has been on prednisone therapy for the past 6 months.The patient presents with Cushingoid features, including central obesity, moon facies, and purple striae on the abdomen.Laboratory tests show elevated blood glucose levels and decreased bone mineral density.Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter (ICD-10-CM code T380X5D): Verbatim_EHR_quote_justifying_the_code: \"Patient with a history of prednisone therapy presenting with Cushingoid features and abnormal lab results consistent with glucocorticoid adverse effects.\"The patient reports compliance with prednisone therapy and is here for a follow-up visit to address the side effects.Discontinuation of prednisone therapy and initiation of a tapering regimen. Referral to endocrinology for further management.45FemaleCaucasian"
    },
    "8023": {
        "explanation_text": "Adverse effect of glucocorticoids and synthetic analogues, sequela.",
        "symptom_text": "The patient has a history of asthma and was recently prescribed a high dose of prednisone for an acute exacerbation of their asthma symptoms.The patient presents with muscle weakness and easy bruising.Laboratory tests show elevated blood glucose levels and decreased bone mineral density on DEXA scan.Adverse effect of glucocorticoids and synthetic analogues, sequela. Verbatim EHR quote justifying the code: 'Patient presents with muscle weakness and easy bruising following a recent high-dose prednisone therapy for asthma exacerbation.'The patient reports that their symptoms started shortly after starting the prednisone treatment. Physical examination reveals thinning of the skin and purplish striae on the abdomen.Discontinuation of prednisone therapy. Initiation of physical therapy for muscle weakness. Endocrinology consult for management of glucocorticoid-induced hyperglycemia.The patient's symptoms have improved with the cessation of prednisone. They are advised to follow up with Endocrinology for long-term management of hyperglycemia.45FemaleCaucasian"
    },
    "8024": {
        "explanation_text": "Underdosing of glucocorticoids and synthetic analogues, initial encounter.",
        "symptom_text": "The patient has a history of asthma and seasonal allergies, for which they have been prescribed inhaled glucocorticoids. There is no history of adverse drug reactions.The patient presents with worsening asthma symptoms despite compliant use of inhaled glucocorticoids.Pulmonary function tests show a decrease in FEV1, indicating poor asthma control.Underdosing of glucocorticoids and synthetic analogues, initial encounter. The patient presents with worsening asthma symptoms despite compliant use of inhaled glucocorticoids.The patient reports using their inhaled glucocorticoids as prescribed without missing any doses. However, the worsening asthma control suggests a possible underdosing scenario.Increased dose of inhaled glucocorticoids and a short course of oral corticosteroids. Follow-up scheduled in two weeks.The patient responded well to the increased dose of inhaled glucocorticoids and oral corticosteroids. Symptoms improved, and the patient was discharged home with a follow-up plan in place.45FemaleCaucasian"
    },
    "8025": {
        "explanation_text": "Adverse effect of thyroid hormones and substitutes, initial encounter.",
        "symptom_text": "The patient has a history of hypothyroidism and has been on levothyroxine therapy for the past 5 years without any reported adverse effects.The patient presents with palpitations, weight loss, and heat intolerance since starting a new brand of levothyroxine two weeks ago.Thyroid function tests show suppressed TSH levels and elevated free T4 levels, consistent with thyrotoxicosis induced by the recent change in levothyroxine.Adverse effect of thyroid hormones and substitutes, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with symptoms of thyrotoxicosis, including palpitations, weight loss, and heat intolerance, along with abnormal thyroid function tests showing suppressed TSH and elevated free T4 levels after a recent change in levothyroxine therapy.'The patient's symptoms and lab results are indicative of an adverse effect of the new levothyroxine brand, leading to thyrotoxicosis. Discontinue the current levothyroxine brand and initiate beta-blockers for symptom control.Discontinued the new levothyroxine brand and started the patient on beta-blockers for symptom management. Plan for close monitoring of thyroid function tests.The patient responded well to the treatment provided, with resolution of symptoms. Discharged home with a prescription for an alternative levothyroxine brand and follow-up scheduled in two weeks.45FemaleCaucasian"
    },
    "8026": {
        "explanation_text": "Underdosing of thyroid hormones and substitutes, initial encounter.",
        "symptom_text": "The patient has a history of hypothyroidism and has been on thyroid hormone replacement therapy for the past 5 years.The patient presents with fatigue, weight gain, cold intolerance, and dry skin.Thyroid function tests show elevated TSH levels and low free T4 levels, indicating inadequate thyroid hormone replacement.Underdosing of thyroid hormones and substitutes, initial encounter. The patient presents with fatigue, weight gain, cold intolerance, and dry skin, along with elevated TSH levels and low free T4 levels, indicating inadequate thyroid hormone replacement therapy.Patient reports non-compliance with prescribed thyroid hormone replacement therapy. Plan to educate the patient on the importance of adherence to the medication regimen.Increased dosage of thyroid hormone replacement therapy prescribed. Follow-up appointment scheduled in 4 weeks to monitor thyroid function.42FemaleCaucasian"
    },
    "8027": {
        "explanation_text": "Poisoning by insulin and oral hypoglycemic [antidiabetic] drugs, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has a history of type 2 diabetes mellitus and has been prescribed insulin and oral hypoglycemic drugs for glycemic control.The patient presents with confusion, diaphoresis, tachycardia, and tremors.Blood tests show hypoglycemia with elevated levels of insulin and oral hypoglycemic drugs.Poisoning by insulin and oral hypoglycemic [antidiabetic] drugs, accidental (unintentional), initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with symptoms of confusion, diaphoresis, tachycardia, and tremors along with laboratory results showing hypoglycemia and elevated levels of insulin and oral hypoglycemic drugs, consistent with accidental poisoning.'The patient's family mentioned an unintentional double dose of insulin and oral hypoglycemic drugs taken by the patient due to confusion in the medication schedule.The patient was treated with intravenous dextrose for hypoglycemia reversal and close monitoring of blood glucose levels.The patient's condition improved with treatment, and education was provided to the patient and family regarding medication management to prevent future incidents.55FemaleCaucasian"
    },
    "8028": {
        "explanation_text": "Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter.",
        "symptom_text": "The patient has a history of type 2 diabetes mellitus and has been on insulin and oral hypoglycemic medications for the past five years.The patient presents with symptoms of hypoglycemia, including sweating, palpitations, and confusion.Blood glucose levels are significantly low at 50 mg/dL, confirming hypoglycemia.Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with symptoms of hypoglycemia, including sweating, palpitations, and confusion, with low blood glucose levels at 50 mg/dL.'The patient responded well to oral glucose administration in the emergency room, with resolution of symptoms.The patient was advised on proper insulin dosage adjustments and educated on recognizing and managing hypoglycemic episodes.The patient was discharged home in stable condition with instructions to monitor blood glucose levels closely and follow up with their endocrinologist in one week.55FemaleCaucasian"
    },
    "8029": {
        "explanation_text": "Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter.",
        "symptom_text": "The patient has a history of type 2 diabetes mellitus and has been prescribed insulin and oral hypoglycemic drugs for glycemic control.The patient presents with elevated blood glucose levels despite compliance with the prescribed insulin and oral antidiabetic medications.Fasting blood glucose levels are consistently above the target range, indicating inadequate response to the current antidiabetic regimen.Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter. Verbatim EHR quote justifying the code: 'Patient presenting with elevated blood glucose levels despite compliance with prescribed insulin and oral antidiabetic medications.'The physician notes the importance of optimizing the patient's antidiabetic medication regimen to achieve better glycemic control and prevent complications associated with uncontrolled diabetes.The patient's insulin and oral antidiabetic drug dosages have been adjusted to achieve target blood glucose levels. The patient has been educated on proper medication administration and monitoring.55FemaleCaucasian"
    },
    "8030": {
        "explanation_text": "Adverse effect of oral contraceptives, initial encounter.",
        "symptom_text": "The patient has been using oral contraceptives for birth control for the past two years without any reported adverse effects. No history of other chronic medical conditions or recent medication changes.The patient presents with mild nausea and breast tenderness, which started shortly after switching to a new brand of oral contraceptives. No other symptoms reported.Pregnancy test result is negative. Basic metabolic panel and liver function tests are within normal limits.Adverse effect of oral contraceptives, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with symptoms of mild nausea and breast tenderness following a recent change in oral contraceptive brand.'Patient denies any other significant symptoms. Physical examination reveals no abnormalities other than mild breast tenderness. No signs of infection or other systemic issues.Recommendation to switch back to the previous oral contraceptive brand. Advised on managing mild symptoms with over-the-counter remedies. Follow-up scheduled in two weeks.27FemaleCaucasian"
    },
    "8031": {
        "explanation_text": "Adverse effect of androgens and anabolic congeners, initial encounter.",
        "symptom_text": "The patient has a history of using androgens and anabolic congeners for performance enhancement.The patient presents with acne, oily skin, and increased facial and body hair, which are consistent with androgen excess.Laboratory tests show elevated levels of testosterone and its metabolites, confirming androgen exposure.Adverse effect of androgens and anabolic congeners, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with symptoms of androgen excess, including acne, oily skin, and increased facial and body hair. Laboratory tests reveal elevated testosterone levels, confirming exposure to androgens and anabolic congeners.'The patient reports the onset of symptoms after starting a new regimen of androgens and anabolic congeners for bodybuilding purposes.Discontinuation of the androgens and anabolic congeners. Symptomatic treatment for acne and oily skin.The patient responded well to the treatment and was discharged with instructions to avoid androgens and anabolic congeners in the future.28MaleCaucasian"
    },
    "8032": {
        "explanation_text": "Adverse effect of other hormones and synthetic substitutes, initial encounter.",
        "symptom_text": "The patient has a history of hypopituitarism and is currently on hormone replacement therapy with synthetic hormones.The patient presents with fatigue, weight loss, and hypotension.Laboratory tests show low levels of cortisol and thyroid hormones.Adverse effect of other hormones and synthetic substitutes, initial encounter. Verbatim_EHR_quote_justifying_the_code: \"The patient presents with symptoms of fatigue, weight loss, and hypotension, along with laboratory findings of low cortisol and thyroid hormone levels, consistent with adverse effects of other hormones and synthetic substitutes.\"The patient reports these symptoms started after the initiation of hormone replacement therapy. Physical examination shows no signs of infection or other systemic diseases.Discontinuation of the current synthetic hormones with close monitoring of symptoms. Introduction of alternative hormone replacement therapy.The patient responded well to the treatment plan and was discharged with a follow-up appointment in two weeks.45FemaleCaucasian"
    },
    "8033": {
        "explanation_text": "Adverse effect of aspirin, initial encounter.",
        "symptom_text": "The patient has a history of occasional headaches and no known drug allergies.The patient presents with epigastric pain, nausea, and vomiting after taking aspirin.Laboratory tests show no signs of infection or other abnormalities.Adverse effect of aspirin, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with epigastric pain, nausea, and vomiting after taking aspirin.'The physician notes that the symptoms started shortly after the patient took aspirin for a headache.The patient was advised to stop taking aspirin and was prescribed a proton pump inhibitor for gastritis symptoms.The patient's symptoms improved with treatment, and they were discharged with instructions to avoid aspirin and follow up if symptoms persist.45FemaleCaucasian"
    },
    "8034": {
        "explanation_text": "Underdosing of aspirin, initial encounter.",
        "symptom_text": "The patient has a history of cardiovascular disease and has been prescribed aspirin for secondary prevention.The patient presents with recurrent chest pain and palpitations.Lab tests show subtherapeutic levels of salicylates in the blood.Underdosing of aspirin, initial encounter. Verbatim EHR quote justifying the code: 'Patient diagnosed with underdosing of aspirin due to subtherapeutic levels of salicylates in the blood.'The physician notes the importance of optimizing aspirin therapy to prevent adverse cardiovascular events.The patient was advised to increase the aspirin dose as per medical recommendations.The patient was discharged in stable condition with close follow-up for aspirin therapy optimization.58MaleCaucasian"
    },
    "8035": {
        "explanation_text": "Poisoning by 4-Aminophenol derivatives, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has no known history of allergies or previous poisonings. No history of diabetes or endocrine disorders.The patient presented with nausea, vomiting, abdominal pain, and dizziness after accidentally ingesting a substance suspected to be 4-Aminophenol derivatives.Blood tests revealed elevated levels of 4-Aminophenol derivatives in the patient's system, confirming poisoning.Poisoning by 4-Aminophenol derivatives, accidental (unintentional), initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presented with symptoms of nausea, vomiting, abdominal pain, and dizziness after accidental ingestion of a substance suspected to be 4-Aminophenol derivatives. Diagnostic blood tests confirmed elevated levels of 4-Aminophenol derivatives.'The patient is stable and responsive. No signs of intentional self-harm or suicidal ideation. Continued monitoring for any developing symptoms or complications.The patient was treated with activated charcoal to limit absorption and supportive care to manage symptoms. Close observation for any adverse effects.The patient responded well to treatment with resolution of symptoms. Discharged with instructions for follow-up monitoring and to avoid exposure to 4-Aminophenol derivatives.42FemaleCaucasian"
    },
    "8036": {
        "explanation_text": "Poisoning by 4-Aminophenol derivatives, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of depression and recent social stressors.Upon admission, the patient presented with nausea, vomiting, abdominal pain, and altered mental status.Laboratory tests revealed elevated liver enzymes and metabolic acidosis.Poisoning by 4-Aminophenol derivatives, intentional self-harm, initial encounter. Verbatim EHR quote justifying the code: 'Patient admitted with intentional ingestion of 4-Aminophenol derivatives, presenting with symptoms of nausea, vomiting, abdominal pain, altered mental status, along with laboratory findings of elevated liver enzymes and metabolic acidosis.'The patient admitted to ingesting a significant amount of 4-Aminophenol derivatives with suicidal intent. Close monitoring for hepatic failure and supportive care initiated.The patient received activated charcoal, N-acetylcysteine, and supportive care in the intensive care unit.After stabilization and improvement in liver function tests, the patient was transferred to the psychiatric unit for further evaluation and management of underlying mental health conditions.42FemaleCaucasian"
    },
    "8037": {
        "explanation_text": "Adverse effect of 4-Aminophenol derivatives, initial encounter.",
        "symptom_text": "The patient has no known allergies to medications. No history of diabetes, oral contraceptive use, or other relevant medical conditions.The patient presents with nausea, vomiting, abdominal pain, and dark urine after taking a medication containing 4-Aminophenol derivatives.Liver function tests show elevated liver enzymes consistent with drug-induced hepatotoxicity.Adverse effect of 4-Aminophenol derivatives, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with symptoms of nausea, vomiting, abdominal pain, and dark urine following ingestion of a medication containing 4-Aminophenol derivatives. Lab results indicate elevated liver enzymes.'The patient denies any recent changes in diet or other medication use. Physical examination reveals jaundice and tenderness in the right upper quadrant.Immediate discontinuation of the suspected medication. Supportive care for drug-induced liver injury with close monitoring of liver function.Patient responded well to treatment with resolution of symptoms. Liver enzymes trended down, and the patient was discharged with instructions to avoid medications containing 4-Aminophenol derivatives.45FemaleCaucasian"
    },
    "8038": {
        "explanation_text": "Poisoning by propionic acid derivatives, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of depression and anxiety, with no known history of substance abuse or intentional self-harm.The patient presents with nausea, vomiting, abdominal pain, and altered mental status.Blood tests show metabolic acidosis and elevated levels of propionic acid derivatives.Poisoning by propionic acid derivatives, intentional self-harm, initial encounter. Verbatim EHR quote justifying the code: 'Patient admitted with symptoms of nausea, vomiting, abdominal pain, altered mental status, and diagnostic tests revealing metabolic acidosis and elevated levels of propionic acid derivatives.'The patient admitted to ingesting propionic acid derivatives with suicidal intent. Immediate medical intervention and psychiatric evaluation were initiated.The patient received supportive care, including IV fluids, gastric lavage, and activated charcoal. Psychiatric consultation was requested for further evaluation and management.The patient's condition improved with treatment, and psychiatric follow-up was scheduled upon discharge.32FemaleCaucasian"
    },
    "8039": {
        "explanation_text": "Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter.",
        "symptom_text": "The patient has a history of occasional migraines managed with over-the-counter pain relievers.The patient presents with epigastric pain, heartburn, and occasional nausea.Upper endoscopy revealed mild gastritis without any signs of gastrointestinal bleeding.Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with epigastric pain, heartburn, and occasional nausea after recent NSAID use. Endoscopy shows mild gastritis, supporting the diagnosis of adverse effects due to NSAIDs.'Patient advised to discontinue NSAID use and switch to acetaminophen for pain relief. Prescribed pantoprazole for gastritis.1. Discontinue NSAID use. 2. Start acetaminophen for pain. 3. Prescribe pantoprazole 40 mg once daily for gastritis.The patient responded well to treatment and was discharged with instructions to follow up with their primary care provider in two weeks.45FemaleCaucasian"
    },
    "8040": {
        "explanation_text": "Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela.",
        "symptom_text": "The patient has a history of chronic knee pain due to osteoarthritis and has been on NSAIDs for the past two years.The patient presents with abdominal pain, nausea, and melena.Laboratory tests show no signs of infection or other abnormalities. Fecal occult blood test is positive.Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela. Verbatim: 'Patient developed gastrointestinal bleeding due to prolonged NSAID use.'The patient reports that the symptoms started a week ago after taking NSAIDs for knee pain. Physical examination reveals tenderness in the epigastric region.Discontinuation of NSAIDs. Initiation of proton pump inhibitors for gastric protection. Close monitoring of hemoglobin levels.The patient's symptoms improved with the treatment provided. Discharged with instructions to avoid NSAIDs and follow up with gastroenterology for further evaluation.65FemaleCaucasian"
    },
    "8041": {
        "explanation_text": "Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter.",
        "symptom_text": "The patient has a history of occasional headaches and muscle pain for which they occasionally take over-the-counter nonopioid analgesics and antipyretics.The patient presented with nausea, vomiting, and abdominal pain after taking a nonopioid analgesic for a headache.Laboratory tests showed no signs of liver or kidney dysfunction.Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter. Verbatim EHR quote justifying the code: 'Patient presented with nausea, vomiting, and abdominal pain after taking a nonopioid analgesic for a headache.'The patient denied any history of drug abuse or intentional overdose. No signs of respiratory distress or neurological deficits were observed.The patient was treated symptomatically with antiemetics and intravenous fluids. The nonopioid analgesic was discontinued.The patient's symptoms resolved with treatment, and they were discharged with instructions to avoid the offending medication. Follow-up with a primary care provider was recommended.45FemaleCaucasian"
    },
    "8042": {
        "explanation_text": "Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter.",
        "symptom_text": "The patient has a history of occasional headaches and muscle pain for which they take over-the-counter pain relievers.The patient presented with nausea, vomiting, and abdominal pain shortly after taking an unspecified pain medication.Laboratory tests showed no abnormalities in liver function tests or renal function.Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter. The patient developed nausea, vomiting, and abdominal pain shortly after taking an unspecified pain medication.The patient reports no known allergies to medications. Vital signs are stable. Advised the patient to discontinue the medication and provided supportive care.The patient was given intravenous fluids and antiemetic medication to alleviate symptoms. Observation for any improvement and discharged with instructions to avoid the medication.The patient's symptoms improved with treatment, and they were discharged in stable condition with instructions to follow up if symptoms reoccur.45FemaleCaucasian"
    },
    "8043": {
        "explanation_text": "Poisoning by heroin, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of depression and substance abuse.Upon arrival, the patient presented with pinpoint pupils, respiratory depression, altered mental status, and track marks on the arms.Toxicology screening confirmed the presence of heroin in the patient's system.Poisoning by heroin, intentional self-harm, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient admitted with symptoms consistent with heroin poisoning and toxicology results positive for heroin.'The patient admitted to ingesting a large amount of heroin with suicidal intent. Close monitoring for respiratory depression and overdose complications was initiated.The patient was treated with naloxone for opioid toxicity reversal and admitted to the intensive care unit for further monitoring.Following stabilization and psychiatric evaluation, the patient was discharged to a mental health facility for ongoing care and support.32MaleCaucasian"
    },
    "8044": {
        "explanation_text": "Poisoning by other opioids, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has a history of chronic pain managed with prescription opioids.Upon arrival, the patient presented with altered mental status, respiratory depression, and pinpoint pupils.Toxicology screening revealed the presence of opioids in the patient's system.Accidental poisoning by other opioids, initial encounter. Verbatim ICD-10-CM's verbatim_EHR_quote_justifying_the_code field: 'Accidental poisoning by other opioids, initial encounter.'The patient is suspected to have ingested a higher dose of their prescribed opioid medication accidentally.The patient was treated with naloxone for opioid overdose reversal and admitted for close monitoring.The patient responded well to treatment and was discharged in stable condition with recommendations for pain management alternatives.42MaleCaucasian"
    },
    "8045": {
        "explanation_text": "Underdosing of other opioids, initial encounter.",
        "symptom_text": "The patient has a history of chronic pain due to osteoarthritis and has been prescribed opioids for pain management.The patient presents with increased pain levels, reduced mobility, and decreased quality of life.Laboratory tests show no signs of organ damage or toxicity related to opioid use.Underdosing of other opioids, initial encounter. Verbatim EHR quote justifying the code: 'The patient's increased pain levels and decreased quality of life are consistent with the underdosing of opioids, leading to ineffective pain management.'The physician notes the importance of optimizing the patient's opioid therapy to adequately manage their chronic pain and improve their quality of life.The patient will receive a revised opioid prescription with close monitoring of pain levels and functional status.The patient is discharged with instructions for follow-up appointments to assess the response to the adjusted opioid regimen.65FemaleCaucasian"
    },
    "8046": {
        "explanation_text": "Poisoning by methadone, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has a history of chronic pain management with methadone prescribed by a pain specialist.Upon admission, the patient presented with respiratory depression, pinpoint pupils, and drowsiness.Blood tests revealed elevated methadone levels, confirming the diagnosis.Poisoning by methadone, accidental (unintentional), initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient admitted with respiratory depression, pinpoint pupils, and confirmed elevated methadone levels.'Patient's family confirmed the accidental ingestion of additional methadone tablets beyond the prescribed dose.The patient was monitored closely, received supportive care, and was administered naloxone to reverse the effects of methadone.The patient responded well to treatment, and after stabilization, was discharged with a plan for close follow-up with the pain specialist.45MaleCaucasian"
    },
    "8047": {
        "explanation_text": "Adverse effect of methadone, initial encounter.",
        "symptom_text": "The patient has a history of chronic pain managed with methadone for the past year due to lumbar disc herniation.The patient presents with drowsiness, pinpoint pupils, constipation, and mild respiratory depression.Urine toxicology screen positive for methadone.Adverse effect of methadone, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with symptoms consistent with an adverse effect of methadone including drowsiness, pinpoint pupils, constipation, and mild respiratory depression. Urine toxicology screen positive for methadone.'The patient reports inadvertently taking an extra dose of methadone yesterday which led to the symptoms. No signs of intentional overdose or use of other substances.The patient was monitored closely, and supportive care was provided. Methadone dosage was adjusted under close supervision.The patient's symptoms resolved with dose adjustment. Patient educated on the importance of adhering to the prescribed methadone regimen to prevent adverse effects.45MaleCaucasian"
    },
    "8048": {
        "explanation_text": "Poisoning by cocaine, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has no known history of substance abuse but reports occasional social cocaine use.Upon arrival, the patient presented with tachycardia, diaphoresis, dilated pupils, and restlessness.Toxicology screening confirmed the presence of cocaine in the patient's system.Poisoning by cocaine, accidental (unintentional), initial encounter. Verbatim_EHR_quote_justifying_the_code: 'The patient's symptoms, toxicology screening results, and history of occasional social cocaine use are consistent with a diagnosis of poisoning by cocaine, accidental (unintentional), initial encounter.'The patient denied any suicidal ideation or intent. There were no signs of injection marks or track marks on examination.The patient was monitored closely, received intravenous fluids, and was observed until symptoms resolved.The patient's symptoms improved, and they were discharged with a referral to a substance abuse counselor for further evaluation and support.32MaleCaucasian"
    },
    "8049": {
        "explanation_text": "Poisoning by cocaine, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of depression and previous suicide attempts.Upon admission, the patient presented with tachycardia, diaphoresis, dilated pupils, and agitation.Toxicology screening confirmed the presence of cocaine in the patient's system.Poisoning by cocaine, intentional self-harm, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient admitted after intentional ingestion of cocaine with clinical signs and toxicology results confirming the poisoning.'The patient admitted to ingesting a large quantity of cocaine with suicidal intent. No other substances were reported or found in toxicology screening.The patient was closely monitored in the ICU, received activated charcoal, intravenous fluids, and benzodiazepines for agitation.Following stabilization and psychiatric evaluation, the patient was referred to outpatient mental health services for further management of their underlying depression and suicidal ideation.34MaleCaucasian"
    },
    "8050": {
        "explanation_text": "Adverse effect of unspecified narcotics, initial encounter.",
        "symptom_text": "The patient has a history of chronic pain managed with prescription pain medications.The patient presents with nausea, dizziness, and confusion.Urine toxicology screening is positive for opioids.Adverse effect of unspecified narcotics, initial encounter. Verbatim: 'Patient presents with nausea, dizziness, and confusion along with a positive urine toxicology screening for opioids, consistent with an adverse effect of unspecified narcotics.'The patient denies any suicidal ideation or intent. The symptoms are consistent with an adverse reaction to opioid medications.The patient was monitored closely, provided supportive care, and advised to discontinue the current opioid medication.The patient's symptoms improved with supportive care, and upon resolution, the patient was discharged home with instructions to follow up with their primary care physician.52FemaleCaucasian"
    },
    "8051": {
        "explanation_text": "Adverse effect of inhaled anesthetics, initial encounter.",
        "symptom_text": "The patient has no history of substance abuse, allergies, or adverse drug reactions.Upon exposure to inhaled anesthetics, the patient presented with wheezing, shortness of breath, and hypoxemia.Pulmonary function tests showed a restrictive pattern with decreased lung volumes and impaired gas exchange.Adverse effect of inhaled anesthetics, initial encounter. Verbatim EHR quote justifying the code: 'Patient developed wheezing, shortness of breath, and hypoxemia following exposure to inhaled anesthetics.'The patient's symptoms are consistent with an adverse reaction to inhaled anesthetics. No signs of substance abuse or overdose were noted.The patient was treated with supplemental oxygen, bronchodilators, and close monitoring of respiratory status.The patient responded well to treatment and was discharged home with instructions to avoid inhaled anesthetics in the future.45FemaleCaucasian"
    },
    "8052": {
        "explanation_text": "Adverse effect of unspecified general anesthetics, initial encounter.",
        "symptom_text": "The patient has no known history of adverse reactions to medications or anesthetics.Upon administration of the general anesthetic, the patient developed sudden shortness of breath, hypotension, and generalized skin rash.Laboratory tests revealed no abnormalities in blood counts, electrolytes, or organ function tests that could explain the symptoms.Adverse effect of unspecified general anesthetics, initial encounter. Verbatim EHR quote justifying the code: 'Patient presented with sudden shortness of breath, hypotension, and generalized skin rash following administration of unspecified general anesthetics.'The patient's symptoms are consistent with an adverse reaction to the general anesthetic, and no other identifiable cause for the symptoms was found upon initial evaluation.The patient was treated with intravenous fluids, antihistamines, and corticosteroids to manage the allergic reaction. Vital signs were closely monitored.The patient's symptoms resolved after treatment, and no further complications were observed upon discharge.42FemaleCaucasian"
    },
    "8053": {
        "explanation_text": "Adverse effect of other general anesthetics, initial encounter.",
        "symptom_text": "The patient has no known history of adverse reactions to medications or anesthesia.Upon administration of the general anesthetic, the patient experienced sudden shortness of breath, wheezing, and a drop in blood pressure.Blood tests revealed an elevated white blood cell count, which could be indicative of an allergic reaction.Adverse effect of other general anesthetics, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with acute respiratory distress, hypotension, and elevated white blood cell count following administration of general anesthesia.'The patient responded well to oxygen therapy and intravenous fluids. Monitoring showed a gradual improvement in vital signs post-treatment.Treatment included oxygen therapy to address respiratory distress and intravenous fluids to stabilize blood pressure.The patient's condition significantly improved post-treatment, and no further adverse effects were observed upon discharge.45FemaleCaucasian"
    },
    "8054": {
        "explanation_text": "Adverse effect of local anesthetics, initial encounter.",
        "symptom_text": "The patient has no known allergies to medications, including local anesthetics. No history of substance abuse or dependence. No previous adverse reactions to anesthesia reported.The patient presents with localized numbness and tingling at the site of administration of the local anesthetic. There are no systemic symptoms such as dizziness, confusion, or respiratory distress.Physical examination shows no signs of anaphylaxis or severe allergic reaction. Laboratory tests are unremarkable, ruling out metabolic or electrolyte imbalances.Adverse effect of local anesthetics, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with localized numbness and tingling at the site of local anesthetic administration, without systemic symptoms or signs of anaphylaxis.'The patient is alert and oriented, with stable vital signs. No evidence of respiratory compromise or cardiovascular instability. The localized symptoms are consistent with a mild adverse reaction to the local anesthetic.The patient was monitored closely for any progression of symptoms. Symptomatic treatment with topical agents for the localized numbness was initiated. No additional interventions were required.The patient responded well to treatment, with the symptoms gradually resolving. Discharged in stable condition with instructions for follow-up if needed.42FemaleCaucasian"
    },
    "8055": {
        "explanation_text": "Adverse effect of unspecified anesthetic, initial encounter.",
        "symptom_text": "The patient has no history of adverse reactions to medications or anesthetics.Upon administration of the unspecified anesthetic, the patient developed sudden shortness of breath, tachycardia, and skin rash.Blood tests showed no abnormalities in electrolyte levels or cardiac enzymes.Adverse effect of unspecified anesthetic, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presented with sudden shortness of breath, tachycardia, and skin rash following the administration of an unspecified anesthetic.'The patient's symptoms are consistent with an adverse reaction to the anesthetic. Close monitoring for respiratory distress and cardiac complications is advised.The patient was treated with antihistamines, oxygen therapy, and close cardiac monitoring. The anesthetic was discontinued.The patient's condition improved with treatment, and no further adverse effects were observed upon discharge.42FemaleCaucasian"
    },
    "8056": {
        "explanation_text": "Adverse effect of iminostilbenes, initial encounter.",
        "symptom_text": "The patient has no history of exposure to other medications known to cause similar adverse effects.The patient presents with nausea, vomiting, and dizziness following the ingestion of iminostilbenes.Laboratory tests show no abnormalities other than those consistent with the adverse effect of iminostilbenes.Adverse effect of iminostilbenes, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with symptoms of nausea, vomiting, and dizziness after ingestion of iminostilbenes.'The physician notes the temporal relationship between the ingestion of iminostilbenes and the onset of symptoms.Supportive care provided, including antiemetics and close monitoring of vital signs.The patient's symptoms improved with treatment, and they were discharged home with instructions to avoid iminostilbenes in the future.45MaleCaucasian"
    },
    "8057": {
        "explanation_text": "Adverse effect of barbiturates, initial encounter.",
        "symptom_text": "The patient has a history of insomnia and was prescribed barbiturates for sleep induction.The patient presents with drowsiness, confusion, and shallow breathing.Serum barbiturate levels are elevated, consistent with toxicity.Adverse effect of barbiturates, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with symptoms of drowsiness, confusion, and shallow breathing, along with elevated serum barbiturate levels.'Patient's symptoms are consistent with barbiturate toxicity. Discontinue barbiturate use immediately.Supportive care provided, including close monitoring of vital signs and respiratory function.Patient's condition improved with supportive care. Discharged with instructions to avoid barbiturates.45FemaleCaucasian"
    },
    "8058": {
        "explanation_text": "Poisoning by benzodiazepines, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has a history of anxiety and was prescribed benzodiazepines for the past year.The patient presented with drowsiness, confusion, slurred speech, and ataxia.Laboratory tests confirmed the presence of benzodiazepines in the patient's blood.Poisoning by benzodiazepines, accidental (unintentional), initial encounter. Verbatim_EHR_quote_justifying_the_code: The patient accidentally ingested benzodiazepines, leading to symptoms of drowsiness, confusion, slurred speech, and ataxia. Laboratory tests confirmed the presence of benzodiazepines in the blood, supporting the diagnosis of accidental poisoning.The patient's family mentioned finding an empty bottle of benzodiazepines in the patient's room. The patient is responsive but shows signs of CNS depression.The patient was treated with activated charcoal, monitored closely, and provided supportive care to manage symptoms.The patient's condition improved with treatment, and after ensuring stability, the patient was discharged with instructions to avoid unsupervised access to medications.42MaleCaucasian"
    },
    "8059": {
        "explanation_text": "Poisoning by benzodiazepines, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of anxiety and insomnia for which benzodiazepines were prescribed.The patient presents with drowsiness, confusion, slurred speech, and respiratory depression.Blood tests show elevated benzodiazepine levels consistent with toxicity.Poisoning by benzodiazepines, intentional self-harm, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with symptoms of benzodiazepine toxicity after an intentional overdose.'The patient admitted to taking an excessive amount of benzodiazepines in a suicide attempt.The patient was treated with activated charcoal, close monitoring, and supportive care in the intensive care unit.After stabilization and psychiatric evaluation, the patient was transferred to the psychiatric ward for further management of their underlying mental health condition.38FemaleCaucasian"
    },
    "8060": {
        "explanation_text": "Adverse effect of benzodiazepines, initial encounter.",
        "symptom_text": "The patient has a history of anxiety disorder for which benzodiazepines were prescribed.The patient presented with drowsiness, confusion, and slurred speech.Blood tests showed no abnormalities. Urine drug screen was positive for benzodiazepines.Adverse effect of benzodiazepines, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presented with drowsiness, confusion, and slurred speech after taking benzodiazepines.'The patient's symptoms are consistent with an adverse effect of benzodiazepines. No signs of overdose or intentional self-harm were noted.The patient was monitored closely, benzodiazepine administration was stopped, and supportive care was given.The patient's symptoms resolved with discontinuation of benzodiazepines. Discharged in stable condition with instructions to avoid benzodiazepines.45FemaleCaucasian"
    },
    "8061": {
        "explanation_text": "Poisoning by other antiepileptic and sedative-hypnotic drugs, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has a history of epilepsy and has been prescribed antiepileptic medications for the past five years. No history of intentional drug misuse or self-harm.Upon admission, the patient presented with drowsiness, confusion, slurred speech, and ataxia. No signs of self-inflicted injuries or suicidal ideation.Initial blood tests revealed elevated levels of the specific antiepileptic drug in the bloodstream, confirming acute overdose. No abnormalities in liver or kidney function tests.Poisoning by other antiepileptic and sedative-hypnotic drugs, accidental (unintentional), initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient admitted with symptoms consistent with acute overdose of antiepileptic medications, confirmed by elevated drug levels in the blood.'The patient's clinical presentation and diagnostic results indicate an accidental overdose of antiepileptic drugs. No suicidal intentions or self-harm behaviors observed during the assessment.Immediate gastric lavage was performed to remove the remaining drug from the stomach. The patient received activated charcoal and was closely monitored in the intensive care unit for neurological status and vital signs.After stabilization and symptomatic treatment, the patient showed gradual improvement without any lasting complications. Discharged with recommendations for close follow-up with the neurology department.42MaleCaucasian"
    },
    "8062": {
        "explanation_text": "Poisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of epilepsy and depression, for which they were prescribed antiepileptic and sedative-hypnotic medications. There is no history of accidental overdoses or adverse effects from these medications.The patient presents with altered mental status, slurred speech, confusion, and drowsiness. They deny any memory loss, seizures, or tremors.Laboratory tests show elevated levels of the specific antiepileptic and sedative-hypnotic drugs in the bloodstream, confirming acute toxicity.Poisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm, initial encounter. Verbatim EHR quote justifying the code: The patient intentionally ingested a large amount of antiepileptic and sedative-hypnotic drugs in a suicide attempt.The patient admitted to the intentional ingestion of their prescribed medications in an attempt to harm themselves. There are no signs of accidental ingestion or adverse drug reactions.The patient was treated with gastric lavage, activated charcoal, and close monitoring in the intensive care unit to prevent further absorption of the drugs and manage their symptoms.The patient's condition improved with treatment, and they were psychiatrically evaluated before discharge to ensure appropriate follow-up care for their underlying mental health conditions.42MaleCaucasian"
    },
    "8063": {
        "explanation_text": "Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter.",
        "symptom_text": "The patient has a history of epilepsy and anxiety disorder for which they have been prescribed antiepileptic and sedative-hypnotic medications.The patient presents with drowsiness, ataxia, and confusion after a recent increase in their antiepileptic medication dosage.Laboratory tests show normal electrolyte levels and no signs of infection. EEG shows no epileptiform discharges.Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with drowsiness, ataxia, and confusion following a recent increase in antiepileptic medication dosage.'Patient's vital signs are stable. Neurological examination reveals no focal deficits. The patient's symptoms are consistent with a known adverse effect of antiepileptic and sedative-hypnotic drugs.The patient was advised to decrease the antiepileptic medication dose, provided with supportive care, and scheduled for a follow-up visit in one week.45FemaleCaucasian"
    },
    "8064": {
        "explanation_text": "Underdosing of other antiepileptic and sedative-hypnotic drugs, initial encounter.",
        "symptom_text": "The patient has a history of epilepsy and anxiety disorder, for which they have been prescribed antiepileptic and sedative-hypnotic drugs.The patient presents with increased seizure frequency and heightened anxiety despite regular medication intake.Blood tests indicate subtherapeutic levels of the prescribed antiepileptic and sedative-hypnotic drugs.Underdosing of other antiepileptic and sedative-hypnotic drugs, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with increased seizure frequency and heightened anxiety, consistent with underdosing of antiepileptic and sedative-hypnotic drugs.'Patient reports adherence to the prescribed medication regimen. No signs of intentional overdose or adverse drug reactions observed.Adjusted dosage of antiepileptic and sedative-hypnotic drugs to reach therapeutic levels. Patient education on proper medication adherence.Patient stabilized with the corrected medication dosage and advised for follow-up to monitor drug levels and symptom improvement.42MaleCaucasian"
    },
    "8065": {
        "explanation_text": "Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter.",
        "symptom_text": "The patient has a history of epilepsy and anxiety disorder for which they have been prescribed antiepileptic and sedative-hypnotic drugs.The patient presents with dizziness, drowsiness, and confusion.Laboratory tests show no abnormalities.Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with dizziness, drowsiness, and confusion after taking antiepileptic and sedative-hypnotic drugs.'The patient reports that the symptoms started shortly after a recent change in their medication regimen.Discontinuation of the suspected drugs and symptomatic management with hydration and observation.The patient's symptoms resolved after discontinuing the medications, and they were discharged with recommendations for follow-up with their primary care physician.45FemaleCaucasian"
    },
    "8066": {
        "explanation_text": "Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter.",
        "symptom_text": "The patient has a history of Parkinson's disease and has been on antiparkinsonism drugs for the last two years to manage the condition.The patient presents with increased muscle rigidity, tremors, and difficulty in initiating movements.MRI brain scan shows no acute abnormalities. Blood tests reveal therapeutic levels of antiparkinsonism drugs.Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter. Verbatim EHR quote justifying the code: 'Patient presenting with symptoms of increased muscle rigidity, tremors, and difficulty in initiating movements after recent adjustments in antiparkinsonism medication dosage.'Patient reports that the symptoms started shortly after a change in the dosage of antiparkinsonism medication. No signs of infection or other systemic issues.Discontinuation of the recent adjustments in antiparkinsonism medication dosage. Symptomatic treatment with muscle relaxants. Close monitoring of the patient's motor symptoms.The patient responded well to the treatment and showed a gradual improvement in muscle rigidity and tremors. Discharged with instructions for follow-up with the neurologist in one week.68MaleCaucasian"
    },
    "8067": {
        "explanation_text": "Poisoning by tricyclic antidepressants, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of depression and was prescribed tricyclic antidepressants for the past six months.Upon arrival, the patient presented with altered mental status, dry skin, dilated pupils, and tachycardia.ECG showed a widened QRS complex consistent with tricyclic antidepressant toxicity.Poisoning by tricyclic antidepressants, intentional self-harm, initial encounter. Verbatim from ICD-10-CM: T43012A - Poisoning by tricyclic antidepressants, intentional self-harm, initial encounter.The patient admitted to ingesting a large quantity of tricyclic antidepressants with suicidal intent.The patient was treated with activated charcoal, sodium bicarbonate, and continuous cardiac monitoring.The patient's condition improved with treatment, and psychiatric evaluation was recommended for further management.42FemaleCaucasian"
    },
    "8068": {
        "explanation_text": "Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of depression and has been prescribed selective serotonin and norepinephrine reuptake inhibitors for the past six months.The patient presented with altered mental status, confusion, tachycardia, and mydriasis.Toxicology screening confirmed the presence of selective serotonin and norepinephrine reuptake inhibitors in the patient's system.Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient admitted with altered mental status, tachycardia, and mydriasis following intentional ingestion of selective serotonin and norepinephrine reuptake inhibitors.'The patient admitted to taking an overdose of their prescribed medication following a depressive episode. No other substances were involved.The patient was monitored closely, received activated charcoal, and was started on intravenous fluids for hydration.After stabilization and psychiatric evaluation, the patient was referred for inpatient psychiatric care for further management of their underlying depression and suicidal ideation.42FemaleCaucasian"
    },
    "8069": {
        "explanation_text": "Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter.",
        "symptom_text": "The patient has a history of depression and anxiety for which they have been prescribed selective serotonin and norepinephrine reuptake inhibitors.The patient presents with increased heart rate, elevated blood pressure, tremors, and profuse sweating.Blood tests indicate no abnormalities in electrolyte levels or thyroid function.Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with symptoms of increased heart rate, elevated blood pressure, tremors, and profuse sweating, consistent with the adverse effects of selective serotonin and norepinephrine reuptake inhibitors.'Patient denies any suicidal ideation or intentional self-harm. No signs of underdosing or poisoning observed. Adverse effects likely due to the prescribed medication.Discontinuation of the selective serotonin and norepinephrine reuptake inhibitors. Symptomatic treatment provided to manage the side effects.Patient's symptoms improved with discontinuation of the medication. Advised to follow up with the prescribing physician for alternative treatment options.42FemaleCaucasian"
    },
    "8070": {
        "explanation_text": "Underdosing of selective serotonin and norepinephrine reuptake inhibitors, initial encounter.",
        "symptom_text": "The patient has a history of depression and anxiety disorders for which selective serotonin and norepinephrine reuptake inhibitors were prescribed.The patient presents with worsening depressive symptoms, increased anxiety, and poor response to the current medication regimen.Lab tests show subtherapeutic levels of the prescribed selective serotonin and norepinephrine reuptake inhibitors.Underdosing of selective serotonin and norepinephrine reuptake inhibitors, initial encounter. The patient is not achieving the desired therapeutic effect due to the subtherapeutic levels of the prescribed medication.The patient reports persistent low mood, feelings of hopelessness, and lack of energy despite being compliant with the medication regimen. Adjusted dosage and close monitoring are recommended.Increased dosage of the selective serotonin and norepinephrine reuptake inhibitors as per the psychiatrist's recommendation. Follow-up scheduled in two weeks to assess treatment response.42FemaleCaucasian"
    },
    "8071": {
        "explanation_text": "Poisoning by selective serotonin reuptake inhibitors, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of depression and anxiety for which they were prescribed selective serotonin reuptake inhibitors (SSRIs) by a psychiatrist.The patient presents with altered mental status, drowsiness, nausea, and vomiting.Serum drug levels confirm toxic levels of the prescribed SSRI.Poisoning by selective serotonin reuptake inhibitors, intentional self-harm, initial encounter. Verbatim EHR quote justifying the code: 'Patient admitted with altered mental status, drowsiness, nausea, and vomiting after an intentional overdose of selective serotonin reuptake inhibitors.'The patient admitted to taking a large quantity of their prescribed SSRI in a suicide attempt. The toxicology screen was positive for the specific SSRI ingested.The patient was treated with activated charcoal, monitored closely in the intensive care unit, and received supportive care.After stabilization and psychiatric evaluation, the patient was transferred to the psychiatric ward for further management of their underlying mental health condition.42FemaleCaucasian"
    },
    "8072": {
        "explanation_text": "Underdosing of selective serotonin reuptake inhibitors, initial encounter.",
        "symptom_text": "The patient has a history of major depressive disorder and has been prescribed selective serotonin reuptake inhibitors (SSRIs) for the past year.The patient reports persistent feelings of sadness, loss of interest in activities, fatigue, and poor concentration.Laboratory tests show normal thyroid function, ruling out hypothyroidism as a cause of the symptoms.Underdosing of selective serotonin reuptake inhibitors, initial encounter. The patient presents with symptoms of major depressive disorder and is currently underdosed on SSRIs, leading to persistent depressive symptoms. The underdosing of SSRIs is the primary reason for the patient's current condition.Patient shows no signs of serotonin syndrome or other adverse effects related to SSRIs. The focus is on the inadequate dosage of SSRIs contributing to the ongoing depressive symptoms.The patient's SSRI dosage has been adjusted to the appropriate therapeutic level. Therapy sessions have been scheduled to monitor the patient's progress.The patient is stable and will follow up with the psychiatrist in two weeks for a medication review and symptom reassessment.42FemaleCaucasian"
    },
    "8073": {
        "explanation_text": "Poisoning by other antidepressants, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of depression and anxiety for which they were prescribed an antidepressant. No history of tricyclic or tetracyclic antidepressant use.Upon arrival, the patient presented with altered mental status, dizziness, and nausea. No signs of anticholinergic toxicity or serotonin syndrome.Serum drug levels confirmed the presence of an antidepressant not belonging to the tricyclic or tetracyclic class.Poisoning by other antidepressants, intentional self-harm, initial encounter. Verbatim EHR quote justifying the code: 'Patient admitted after intentional ingestion of a non-tricyclic or tetracyclic antidepressant, presenting with altered mental status and nausea.'Patient conscious but drowsy, pupils equal and reactive. No signs of hypertonicity or hyperreflexia typically seen in tricyclic antidepressant poisoning.Activated charcoal administered, and the patient was closely monitored in the intensive care unit.Patient stabilized, transferred to psychiatric care for further evaluation and management of underlying mental health conditions.42FemaleCaucasian"
    },
    "8074": {
        "explanation_text": "Adverse effect of other antidepressants, initial encounter.",
        "symptom_text": "The patient has a history of depression and anxiety for which they were prescribed an atypical antidepressant medication.The patient presents with nausea, vomiting, and dizziness after taking the new antidepressant medication.Laboratory tests show no abnormalities. ECG is normal.Adverse effect of other antidepressants, initial encounter. Verbatim quote: Adverse effect of other antidepressants, initial encounter.Patient reports the symptoms started shortly after beginning the new antidepressant. No signs of self-harm or intentional poisoning.Discontinuation of the antidepressant medication. Symptomatic treatment for nausea and dizziness. Follow-up scheduled in one week.The patient's symptoms improved with discontinuation of the antidepressant. Advised to follow up if any new symptoms arise.42FemaleCaucasian"
    },
    "8075": {
        "explanation_text": "Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter.",
        "symptom_text": "The patient has a history of schizophrenia and has been on phenothiazine antipsychotic medication for the past two years.The patient presents with acute dystonia, muscle stiffness, and tremors after a recent increase in their antipsychotic medication dosage.Blood tests show no abnormalities. CT scan of the brain is normal.Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter. Verbatim_EHR_quote_justifying_the_code: \"Patient presents with acute dystonia, muscle stiffness, and tremors following a recent increase in antipsychotic medication dosage.\"The patient's symptoms are consistent with an adverse effect of phenothiazine antipsychotics. No signs of butyrophenone or thiothixene neuroleptic toxicity are observed.Treatment includes intramuscular diphenhydramine for acute dystonia and dose adjustment of the antipsychotic medication.The patient's symptoms improved with treatment, and they were discharged with a follow-up appointment in two weeks.42MaleCaucasian"
    },
    "8076": {
        "explanation_text": "Poisoning by other antipsychotics and neuroleptics, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has a history of bipolar disorder and has been prescribed antipsychotic medications for the past two years.Upon admission, the patient presented with altered mental status, confusion, and extrapyramidal symptoms such as dystonia and tremors.Laboratory tests showed elevated creatine kinase levels and a toxicology screen positive for antipsychotic agents.Poisoning by other antipsychotics and neuroleptics, accidental (unintentional), initial encounter. Verbatim EHR quote justifying the code: 'Patient admitted with altered mental status, dystonia, and tremors, along with laboratory findings of elevated creatine kinase and positive toxicology screen for antipsychotic agents.'The patient's symptoms are consistent with antipsychotic and neuroleptic poisoning, and there is no evidence of intentional self-harm.The patient was treated with benzodiazepines for symptom control and underwent supportive care in the intensive care unit.After stabilization and symptomatic improvement, the patient was transferred to the psychiatric unit for further evaluation and management of the underlying bipolar disorder.42FemaleCaucasian"
    },
    "8077": {
        "explanation_text": "Poisoning by other antipsychotics and neuroleptics, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of depression and psychosis, for which they were prescribed antipsychotic medication.The patient presents with altered mental status, confusion, and signs of neuroleptic toxicity like dystonia and tremors.Blood tests show elevated levels of antipsychotic drugs, confirming poisoning.Poisoning by other antipsychotics and neuroleptics, intentional self-harm, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with altered mental status, confusion, and signs of neuroleptic toxicity. Blood tests confirm elevated levels of antipsychotic drugs.'The patient admitted to ingesting a large quantity of their prescribed antipsychotic medication with suicidal intent.The patient was treated with activated charcoal, close monitoring, and supportive care in the psychiatric unit.After stabilization and psychiatric evaluation, the patient was referred for outpatient therapy and follow-up care.42MaleCaucasian"
    },
    "8078": {
        "explanation_text": "Underdosing of other antipsychotics and neuroleptics, initial encounter.",
        "symptom_text": "The patient has a history of schizophrenia and has been on antipsychotic medications for the past 5 years.The patient presents with increased hallucinations, paranoia, and disorganized thinking.Blood tests show subtherapeutic levels of the current antipsychotic medication.Underdosing of other antipsychotics and neuroleptics, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with subtherapeutic levels of antipsychotic medication, leading to worsening psychotic symptoms.'Patient's current symptoms are consistent with underdosing of antipsychotic medications. Plan to adjust the dosage and closely monitor the patient's response.Increased dosage of the current antipsychotic medication and scheduled follow-up in two weeks.42MaleCaucasian"
    },
    "8079": {
        "explanation_text": "Poisoning by amphetamines, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has no history of psychiatric disorders or antidepressant use. There is no history of intentional drug overdose or self-harm.Upon arrival, the patient presented with tachycardia, hypertension, diaphoresis, and mydriasis. The patient was agitated and exhibited signs of confusion.Urine toxicology screening was positive for amphetamines. Blood tests revealed metabolic acidosis.Poisoning by amphetamines, accidental (unintentional), initial encounter. Verbatim EHR quote justifying the code: 'Patient admitted with symptoms of tachycardia, hypertension, diaphoresis, mydriasis, and agitation. Urine toxicology positive for amphetamines. Blood tests show metabolic acidosis.'The patient denied any suicidal ideation or intent. The presentation is consistent with accidental ingestion of amphetamines.The patient was monitored closely in the emergency department. Supportive care was provided, including intravenous fluids and benzodiazepines for sedation.Following treatment, the patient's symptoms improved, and vital signs stabilized. The patient was counseled on the dangers of amphetamine use and discharged with a referral to a substance abuse program.25MaleCaucasian"
    },
    "8080": {
        "explanation_text": "Poisoning by amphetamines, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of depression and anxiety, with previous episodes of intentional self-harm.Upon admission, the patient presented with tachycardia, diaphoresis, agitation, and paranoia.Toxicology screening revealed elevated levels of amphetamines in the blood.Poisoning by amphetamines, intentional self-harm, initial encounter. Verbatim EHR quote justifying the code: 'Patient admitted with intentional ingestion of amphetamines, presenting with tachycardia, diaphoresis, agitation, and paranoia.'The patient admitted to ingesting a large quantity of amphetamines with the intent of self-harm. No evidence of accidental ingestion or adverse effects of other substances.The patient was monitored closely in the intensive care unit, received activated charcoal, intravenous fluids, and benzodiazepines for symptom control.After stabilization and psychiatric evaluation, the patient was transferred to the psychiatric unit for further management of underlying mental health conditions.32FemaleCaucasian"
    },
    "8081": {
        "explanation_text": "Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter.",
        "symptom_text": "The patient has a history of irritable bowel syndrome and anxiety disorder.The patient presents with increased abdominal cramping, urinary retention, and dry mouth.Laboratory tests show no abnormalities.Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'The patient presents with symptoms consistent with underdosing of other parasympatholytics and spasmolytics, including inadequate response to treatment and persistent abdominal cramping.'The patient's symptoms are indicative of a suboptimal response to the current anticholinergic and spasmolytic therapy, suggesting a possible underdosing scenario. Adjusted treatment plan to optimize dosages.Increased dosage of the current anticholinergic and spasmolytic medications. Follow-up scheduled in two weeks.45FemaleCaucasian"
    },
    "8082": {
        "explanation_text": "Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter.",
        "symptom_text": "The patient has a history of asthma and has been using a beta-adrenoreceptor agonist inhaler for the past year.The patient presents with palpitations, tremors, and increased blood pressure.ECG shows sinus tachycardia.Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'The patient presents with palpitations, tremors, and increased blood pressure, consistent with the adverse effects of predominantly beta-adrenoreceptor agonists.'The patient reports using the beta-adrenoreceptor agonist inhaler more frequently in the last few days due to increased asthma symptoms.The patient was advised to reduce the frequency of beta-adrenoreceptor agonist inhaler use and was prescribed a short-acting beta blocker for symptomatic relief.The patient's symptoms improved with the adjusted inhaler use and beta blocker therapy. Discharged home in stable condition.45FemaleCaucasian"
    },
    "8083": {
        "explanation_text": "Underdosing of beta-adrenoreceptor antagonists, initial encounter.",
        "symptom_text": "The patient has a history of hypertension and was recently prescribed beta-adrenoreceptor antagonists for blood pressure management.The patient presents with dizziness, fatigue, and occasional palpitations.ECG shows sinus bradycardia with a heart rate of 55 bpm.Underdosing of beta-adrenoreceptor antagonists, initial encounter. Verbatim: 'Patient diagnosed with underdosing of beta-adrenoreceptor antagonists due to noncompliance with prescribed medication regimen.'The physician notes the importance of medication adherence and the need for patient education on the risks of underdosing beta blockers.The patient was counseled on the significance of compliance with the prescribed beta blocker regimen and provided with educational materials. Dosage adjustment was made under medical supervision.The patient's condition improved with the adjusted medication regimen, and education on adherence was reinforced upon discharge.58FemaleCaucasian"
    },
    "8084": {
        "explanation_text": "Poisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter.",
        "symptom_text": "The patient has a history of seasonal allergies and occasional episodes of nausea and vomiting, for which they were prescribed antiallergic and antiemetic medications in the past.The patient presents with drowsiness, confusion, and slurred speech. They deny any abdominal pain, chest discomfort, palpitations, or shortness of breath.Blood tests show elevated levels of the specific antiallergic and antiemetic drugs in the patient's system. ECG is normal, ruling out cardiac complications.Poisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter. Verbatim EHR quote: 'Patient admitted with intentional ingestion of antiallergic and antiemetic drugs, presenting with drowsiness, confusion, and slurred speech.'The patient admitted to taking a higher dose of their antiallergic and antiemetic medications than prescribed with suicidal intent. No evidence of other drug ingestion or self-harm methods.The patient received activated charcoal for gastric decontamination and was closely monitored in the intensive care unit. Supportive care, including IV fluids and symptomatic treatment, was initiated.Following stabilization and psychiatric evaluation, the patient's condition improved, and they were transferred to the psychiatric ward for further management of their underlying mental health concerns.37MaleCaucasian"
    },
    "8085": {
        "explanation_text": "Adverse effect of antiallergic and antiemetic drugs, initial encounter.",
        "symptom_text": "The patient has a history of seasonal allergies and occasional episodes of nausea and vomiting for which antiallergic and antiemetic drugs were prescribed in the past.The patient presents with dizziness, drowsiness, and mild gastrointestinal discomfort.Laboratory tests show no abnormalities. ECG is within normal limits.Adverse effect of antiallergic and antiemetic drugs, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with dizziness, drowsiness, and mild gastrointestinal discomfort after taking antiallergic and antiemetic drugs.'Patient denies any chest pain, palpitations, or shortness of breath. No signs of an allergic reaction observed. Adverse effects likely due to the prescribed antiallergic and antiemetic drugs.Discontinuation of the antiallergic and antiemetic drugs. Symptomatic treatment for dizziness and gastrointestinal discomfort. Follow-up scheduled in one week.Patient responded well to treatment, symptoms resolved before discharge. Advised to avoid antiallergic and antiemetic drugs in the future unless necessary.42FemaleCaucasian"
    },
    "8086": {
        "explanation_text": "Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has a history of breast cancer and is currently undergoing chemotherapy with antineoplastic drugs.The patient presents with nausea, vomiting, and dizziness after taking their prescribed chemotherapy medication.Blood tests confirm the presence of antineoplastic drugs in the patient's system.Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter. Verbatim EHR quote justifying the code: 'Patient admitted after unintentional ingestion of antineoplastic and immunosuppressive drugs resulting in symptoms of nausea, vomiting, and dizziness.'Patient states that they mistakenly took a double dose of their chemotherapy medication, leading to the symptoms described. No signs of intentional self-harm are present.The patient received supportive care, antiemetic medication, and close monitoring for any adverse effects of the antineoplastic drugs.The patient's symptoms improved with treatment, and they were discharged with instructions to be more cautious with their medication regimen to prevent accidental overdose in the future.54FemaleCaucasian"
    },
    "8087": {
        "explanation_text": "Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter.",
        "symptom_text": "The patient has a history of breast cancer and is currently undergoing chemotherapy with antineoplastic drugs.The patient presents with nausea, vomiting, and fatigue following the recent administration of chemotherapy.Laboratory tests show no signs of infection or electrolyte imbalances, confirming the symptoms are likely due to the adverse effects of the antineoplastic drugs.Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presenting with symptoms of nausea, vomiting, and fatigue following chemotherapy administration.'The patient reports that the symptoms started shortly after the chemotherapy session and have been progressively worsening. Physical examination reveals no other significant findings.The patient was given antiemetic medication to manage nausea and vomiting. Fluid hydration and rest were recommended to alleviate fatigue. Chemotherapy dosages and schedules were adjusted to minimize adverse effects.58FemaleCaucasian"
    },
    "8088": {
        "explanation_text": "Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter.",
        "symptom_text": "The patient has a history of breast cancer and is currently on chemotherapy with antineoplastic drugs.The patient presents with nausea, vomiting, and fatigue following the recent chemotherapy cycle.Lab results show mild leukopenia, which is a known adverse effect of the antineoplastic drugs.Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter. Verbatim_EHR_quote_justifying_the_code: The patient presents with nausea, vomiting, and fatigue following the recent chemotherapy cycle. Lab results show mild leukopenia, which is a known adverse effect of the antineoplastic drugs.The patient reports that the symptoms started a day after the chemotherapy session. Physical examination reveals no signs of infection or other complications.Treatment includes antiemetic medication for nausea, intravenous fluids for hydration, and close monitoring of blood counts.The patient's symptoms improved with treatment, and she was discharged home with instructions to follow up with the oncologist for the next chemotherapy cycle.58FemaleCaucasian"
    },
    "8089": {
        "explanation_text": "Poisoning by anticoagulants, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has a history of atrial fibrillation and was prescribed anticoagulant therapy with warfarin for the past year.The patient presented with unexplained bruising, petechiae, and prolonged bleeding from minor cuts.Coagulation studies revealed an elevated INR of 6.5, consistent with anticoagulant toxicity.Accidental poisoning by anticoagulants, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'The patient presented with unexplained bruising, petechiae, and prolonged bleeding from minor cuts, along with an elevated INR of 6.5, indicative of anticoagulant toxicity.'The patient denied any intentional overdose and reported compliance with the prescribed warfarin regimen. No evidence of self-harm or suicidal ideation was noted.The patient was treated with vitamin K and fresh frozen plasma to reverse the anticoagulant effects. Warfarin was withheld, and the patient was closely monitored for signs of bleeding.Following treatment, the patient's INR normalized, and bleeding symptoms resolved. The patient was educated on the importance of regular INR monitoring and potential drug interactions with warfarin.68MaleCaucasian"
    },
    "8090": {
        "explanation_text": "Underdosing of anticoagulants, initial encounter.",
        "symptom_text": "The patient has a history of atrial fibrillation and deep vein thrombosis.The patient reports increased heart rate, shortness of breath, and leg pain.INR test shows subtherapeutic levels of anticoagulants.Underdosing of anticoagulants, initial encounter. The patient is at increased risk of thromboembolism.The patient's symptoms and subtherapeutic INR levels indicate a potential underdosing of anticoagulants. Close monitoring is required to optimize the anticoagulant therapy.Increased dosage of anticoagulant prescribed. Follow-up scheduled in two weeks for INR monitoring.65FemaleCaucasian"
    },
    "8091": {
        "explanation_text": "Adverse effect of antithrombotic drugs, initial encounter.",
        "symptom_text": "The patient has a history of atrial fibrillation and was prescribed antithrombotic medication for stroke prevention.The patient presented with petechiae on the lower extremities and ecchymosis on the arms.Laboratory tests showed prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT). Imaging studies were unremarkable.Adverse effect of antithrombotic drugs, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with petechiae, ecchymosis, and prolonged PT and aPTT after taking antithrombotic medication.'The patient's symptoms are consistent with a bleeding tendency associated with antithrombotic therapy. Discontinue the current antithrombotic medication and monitor coagulation parameters closely.Discontinued the current antithrombotic medication. Started the patient on supportive care and topical hemostatic agents.The patient's symptoms improved, and coagulation parameters normalized. Discharged home with instructions to follow up with a hematologist for further management.68MaleCaucasian"
    },
    "8092": {
        "explanation_text": "Underdosing of antithrombotic drugs, initial encounter.",
        "symptom_text": "The patient has a history of atrial fibrillation and deep vein thrombosis.The patient presents with recurrent blood clots despite being on antithrombotic therapy.Laboratory tests show subtherapeutic levels of antithrombotic medication in the patient's blood.Underdosing of antithrombotic drugs, initial encounter. Verbatim EHR quote justifying the code: 'The patient presents with recurrent blood clots despite being on antithrombotic therapy.'Patient reports compliance with prescribed antithrombotic medication regimen. No signs of bleeding or drug toxicity observed.Adjusted antithrombotic medication dosage to achieve therapeutic levels. Patient education on proper medication adherence and follow-up testing.Patient discharged in stable condition with close follow-up for monitoring antithrombotic therapy effectiveness.68FemaleCaucasian"
    },
    "8093": {
        "explanation_text": "Adverse effect of thrombolytic drugs, initial encounter.",
        "symptom_text": "The patient has a history of acute myocardial infarction and was recently started on thrombolytic therapy.The patient presents with sudden onset dyspnea, chest pain, and tachycardia after receiving thrombolytic treatment.EKG shows ST-segment elevation indicative of acute myocardial infarction. D-dimer levels are elevated.Adverse effect of thrombolytic drugs, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with symptoms of dyspnea, chest pain, and tachycardia following thrombolytic therapy.'The patient's symptoms started shortly after the administration of thrombolytic drugs, suggesting an adverse reaction to the medication.Discontinuation of thrombolytic therapy. Initiation of supportive care and close monitoring for any further complications.The patient responded well to the discontinuation of thrombolytic therapy and supportive care. Symptoms resolved, and the patient was discharged in stable condition.58MaleCaucasian"
    },
    "8094": {
        "explanation_text": "Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter.",
        "symptom_text": "The patient has a history of atrial fibrillation and was recently started on anticoagulant therapy with warfarin due to a high risk of thromboembolism.The patient presents with petechiae and ecchymosis on the arms and legs, indicative of bleeding under the skin. There are no signs of underdosing, poisoning, or other adverse effects unrelated to anticoagulant antagonists, vitamin K, or other coagulants.Coagulation studies reveal an elevated INR of 4.5, indicating an increased risk of bleeding due to the anticoagulant therapy.Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter. Verbatim EHR quote justifying the code: 'Patient presenting with petechiae, ecchymosis, and elevated INR of 4.5, consistent with adverse effect of anticoagulant therapy.'The patient's symptoms and lab results are in line with an adverse effect of anticoagulant therapy. No evidence of underdosing, poisoning, or other drug-related issues.Discontinuation of warfarin therapy, administration of vitamin K to reverse the anticoagulant effect, and close monitoring of coagulation parameters.The patient responded well to treatment, with resolution of petechiae and ecchymosis. Discharged home with instructions for follow-up INR monitoring.68FemaleCaucasian"
    },
    "8095": {
        "explanation_text": "Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter.",
        "symptom_text": "The patient has a history of hypertension and atrial fibrillation.Upon admission, the patient presented with bradycardia and hypotension.ECG showed prolonged PR interval and ST segment depression.Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Patient presents with bradycardia and hypotension, consistent with the adverse effects of cardiac-stimulant glycosides.'Patient's symptoms improved with the discontinuation of the medication. Recommend close monitoring of cardiac function.Discontinued the cardiac-stimulant glycoside medication. Started the patient on supportive care and monitoring.Patient discharged in stable condition with resolved bradycardia and hypotension.65FemaleCaucasian"
    },
    "8096": {
        "explanation_text": "Poisoning by calcium-channel blockers, accidental (unintentional), initial encounter.",
        "symptom_text": "The patient has a history of hypertension managed with amlodipine, a calcium-channel blocker.Upon arrival, the patient presented with hypotension, bradycardia, and dizziness.Serum calcium levels were within normal limits. ECG showed prolonged QT interval.Poisoning by calcium-channel blockers, accidental (unintentional), initial encounter. Verbatim_EHR_quote_justifying_the_code: 'Accidental poisoning by calcium-channel blockers resulting in hypotension, bradycardia, and prolonged QT interval.'Patient confirmed accidental ingestion of a double dose of amlodipine. No signs of bleeding or clotting disorders.The patient received gastric lavage, activated charcoal, and intravenous calcium for treatment.The patient's condition improved, and after stabilization, was discharged with instructions to avoid amlodipine and follow up with cardiology.58MaleCaucasian"
    },
    "8097": {
        "explanation_text": "Adverse effect of calcium-channel blockers, initial encounter.",
        "symptom_text": "The patient has a history of hypertension managed with amlodipine, a calcium-channel blocker.Upon starting amlodipine, the patient developed dizziness, peripheral edema, and flushing.Electrolyte panel and ECG were performed, showing no abnormalities.Adverse effect of calcium-channel blockers, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with dizziness, peripheral edema, and flushing shortly after initiating amlodipine, consistent with an adverse effect of calcium-channel blockers.'The patient reports no prior history of similar symptoms with other medications. Discontinue amlodipine and consider alternative antihypertensive therapy.Amlodipine was stopped, and the patient was started on lisinopril for blood pressure management.The patient's symptoms improved after discontinuing amlodipine. Discharged home with follow-up in one week.58FemaleCaucasian"
    },
    "8098": {
        "explanation_text": "Underdosing of calcium-channel blockers, initial encounter.",
        "symptom_text": "The patient has a history of hypertension managed with amlodipine, a calcium-channel blocker.The patient presents with dizziness and mild hypotension.Blood tests show low calcium levels.Underdosing of calcium-channel blockers, initial encounter. Verbatim_EHR_quote_justifying_the_code: 'The patient's symptoms and low calcium levels are consistent with underdosing of calcium-channel blockers.'The patient reports forgetting to take their medication for the past week, leading to the symptoms of dizziness and hypotension.The patient was educated on the importance of medication adherence and instructed to resume taking amlodipine as prescribed.The patient's symptoms improved with medication reconciliation and education on adherence. Discharged in stable condition.58FemaleCaucasian"
    },
    "8099": {
        "explanation_text": "Adverse effect of other antidysrhythmic drugs, initial encounter.",
        "symptom_text": "The patient has a history of hypertension and atrial fibrillation, for which they have been prescribed various antidysrhythmic medications in the past.The patient presented with palpitations, dizziness, and shortness of breath after taking a new antidysrhythmic drug.EKG showed irregular heart rhythm consistent with atrial fibrillation. Blood tests indicated no electrolyte imbalances.Adverse effect of other antidysrhythmic drugs, initial encounter. Verbatim EHR quote justifying the code: 'Patient presents with symptoms of palpitations, dizziness, and shortness of breath following the initiation of a new antidysrhythmic medication.'The patient reports no prior history of similar symptoms with previous medications. On examination, irregular heart rhythm was noted, correlating with the EKG findings.The patient was advised to discontinue the new antidysrhythmic drug. They were started on supportive care and monitoring for their symptoms.Patient's symptoms improved with discontinuation of the medication. They were discharged with recommendations for follow-up with a cardiologist for further management of their atrial fibrillation.67MaleCaucasian"
    }
}